Status:
COMPLETED
A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer
Lead Sponsor:
Alaunos Therapeutics
Conditions:
Advanced Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced cancer.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Metastatic and /or unresectable disease state after previous standard chemotherapy
Exclusion
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2007
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00421135
Start Date
February 1 2006
End Date
October 1 2007
Last Update
September 17 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Santa Monica, California, United States
2
Detroit, Michigan, United States